News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference

BOULDER, Colo., Aug. 31, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference in Boston.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.)

Event:                         

Wells Fargo Securities Healthcare Conference

Presenter:                   

Ron Squarer, Chief Executive Officer

Date:                           

Wednesday, September 7, 2016

Time:                          

9:50 a.m. Eastern Time

Webcast:                     

www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:       

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-wells-fargo-securities-healthcare-conference-300315055.html

SOURCE Array BioPharma Inc.